Italy Claims Developing World’s 1st COVID-19 Vaccine That Works On Humans
As the world starts its fifth month seeking to contain and control the COVID-19 pandemic, reports of some possible COVID-19 vaccines have begun to surface thick and strong.
And now, Italy’s news agency ANSA says a firm called Takis has created the world’s first COVID-19 vaccine that produces antibodies in mice operating on human cells.
According to Italian news agency ANSA, the vaccine was checked in Rome’s Spallanzani Hospital, even as Italy’s cumulative number of COVID-19 positive cases reached the 213,000 mark, with over 85,000 recoveries claiming 29,000 lives.
The article states that Luigi Aurisicchio, Takis’ CEO, says that the candidate vaccine first neutralized the COVID-19 virus in human cells.
Neutralizing COVID-19 in human cells
Allowing to CEO Luigi Aurisicchio’s assertion, validated by the Spallanzani Hospital study, Takis is the world’s first firm to successfully prove the complete neutralization of SARS-CoV-2 by a probable human use vaccine.
Italian researchers are cautiously optimistic about Takis’ assertion, noting that the findings are “encouraging and well beyond expectations.” Explaining the antibody production process, Luigi Aurisicchio said experimental mice developed antibodies that can prevent the virus from infecting human cells.
He added that this is the most advanced stage of research for a candidate human vaccine produced entirely in Italy, with large-scale clinical trials planned after this summer.
Aurisicchio also reported Takis is considering a collaboration with an American drug firm, LineaRx, to further refine and update the vaccine formula.
Regarding COVID-19 vaccines This is not the first COVID-19 vaccine neutralizing argument we have seen this week, as researchers in Israel are also creating antibodies that appear to do the same against COVID-19.